Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 3/20 | 1.00 |
| ▸ | NPC1 | O15118 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.79 |
| ▸ | HPGD | P15428 | 5/20 | 0.79 |
| ▸ | GAA | P10253 | 5/20 | 0.79 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.79 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | HIF1A | Q16665 | 10/20 | 0.60 |
| ▸ | GAPDH | P04406 | 1/20 | 0.59 |
| ▸ | MGAM | O43451 | 1/20 | 0.57 |
| ▸ | SI | P14410 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Marmesin SCHEMBL30977125 | 1.00 | ACHE (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin SCHEMBL546574 | 1.00 | ACHE (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin SCHEMBL12062107 | 1.00 | ACHE (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin SCHEMBL503874 | 0.93 | ACHE (0.86) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin Acetate SCHEMBL2257271 | 0.85 | ALDH1A1 (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Marmesin Acetate SCHEMBL12062110 | 0.85 | ALDH1A1 (1.00) | ACHENPC1ALDH1A1HPGDGAA | |
| Felamidin SCHEMBL30467160 | 0.81 | ALDH1A1 (0.75) | ACHENPC1ALDH1A1HPGDGAA | |
| (-)-Prantschimgin SCHEMBL13337338 | 0.81 | ALDH1A1 (0.78) | ACHENPC1ALDH1A1HPGDGAA | |
| Felamidin SCHEMBL12062114 | 0.81 | ALDH1A1 (0.75) | ACHENPC1ALDH1A1HPGDGAA | |
| SCHEMBL30777266 | 0.78 | ALDH1A1 (0.71) | ACHENPC1ALDH1A1HPGDGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714440-A2 | A HEALING HERBAL-MINERAL COMPOSITION WITH ENHANCED EFFECTS | Kurek, Janusz (PL) | 2026-03-25 | — | — | EP | claimed |
| US-20260007728-A1 | COMBINATION THERAPIES INVOLVING L-ASPARAGINASE | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE | 2026-01-08 | — | — | US | claimed |
| EP-4554613-A2 | COMBINATION THERAPIES INVOLVING L-ASPARAGINASE | Jazz Pharmaceuticals Ireland Ltd. (IE) | 2025-05-21 | — | — | EP | claimed |
| WO-2024015529-A2 | COMBINATION THERAPIES INVOLVING L-ASPARAGINASE | JAZZ PHARMACEUTICALS IRELAND LTD. (IE) | 2024-01-18 | — | — | WO | claimed |
| WO-2022170030-A1 | METHOD TO REDUCE INFECTIVITY OF SAMPLES WITH RETENTION OF DIAGNOSTIC SIGNAL | QUIDEL CORPORATION (US) | 2022-08-11 | — | — | WO | claimed |
| WO-2022131639-A1 | COMPOSITION FOR INHIBITING INFLUENZA VIRUS, CONTAINING FERMENTED PRODUCTS OF PLANT EXTRACT COMPRISING NODAKENIN OR NODAKENETIN, OR FRACTIONS THEREOF | 주식회사 엘지생활건강 | 2022-06-23 | — | — | WO | claimed |
| EP-4714440-A2 | A HEALING HERBAL-MINERAL COMPOSITION WITH ENHANCED EFFECTS | Kurek, Janusz (PL) | 2026-03-25 | — | — | EP | disclosed |
| US-12582686-B2 | Manufacturing method for composition promoting recovery of bone fracture | HWANG MAN KI (KR) | 2026-03-24 | — | — | US | disclosed |
| US-12544416-B2 | Manufacturing method for composition promoting bone density enhancement | HWANG MAN KI (KR) | 2026-02-10 | — | — | US | disclosed |
| US-20260007728-A1 | COMBINATION THERAPIES INVOLVING L-ASPARAGINASE | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS COLLATERAL TRUSTEE | 2026-01-08 | — | — | US | disclosed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250388597-A1 | BIFUNCTIONAL PHOTOCROSSLINKING PROBES FOR COVALENT CAPTURE OF PROTEIN-NUCLEIC ACID COMPLEXES IN CELLS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-12-25 | — | — | US | disclosed |
| EP-3973972-B1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA INC (US) | 2025-08-27 | — | — | EP | disclosed |
| WO-2022131639-A1 | COMPOSITION FOR INHIBITING INFLUENZA VIRUS, CONTAINING FERMENTED PRODUCTS OF PLANT EXTRACT COMPRISING NODAKENIN OR NODAKENETIN, OR FRACTIONS THEREOF | 주식회사 엘지생활건강 | 2022-06-23 | — | — | WO | disclosed |
| WO-2022131639-A1 | COMPOSITION FOR INHIBITING INFLUENZA VIRUS, CONTAINING FERMENTED PRODUCTS OF PLANT EXTRACT COMPRISING NODAKENIN OR NODAKENETIN, OR FRACTIONS THEREOF | 주식회사 엘지생활건강 | 2022-06-23 | — | — | WO | disclosed |
| WO-2022131639-A1 | COMPOSITION FOR INHIBITING INFLUENZA VIRUS, CONTAINING FERMENTED PRODUCTS OF PLANT EXTRACT COMPRISING NODAKENIN OR NODAKENETIN, OR FRACTIONS THEREOF | 주식회사 엘지생활건강 | 2022-06-23 | — | — | WO | disclosed |
| US-11340232-B2 | Peptide constructs and assay systems | PROGNOSYS BIOSCIENCES, INC. (US) | 2022-05-24 | — | — | US | disclosed |
| WO-2022090819-A1 | NON-TOXIC FUROCOUMARIN-RICH PLANT EXTRACTS AND RELATED COMPOSITIONS FOR USE AS ANTIMICROBIAL SUBSTANCE OR MEDICAMENT AND OTHER THERAPEUTIC USES | ICE-P LIFE, S.L. (ES) | 2022-05-05 | — | — | WO | disclosed |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | MELALEUCA, INC. | 2022-04-21 | — | — | US | disclosed |
| EP-3973972-A1 | MULTI-SUPPLEMENT COMPOSITIONS | Melaleuca, Inc. (US) | 2022-03-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | ACHE 27/4885NPC1 3237/4885ALDH1A1 1545/4885 |
| US-20260007728-A1 | COMBINATION THERAPIES INVOLVING L-ASPARAGINASE | BCL3, BCL9, BCL9L | ACHE 4205/4885NPC1 3780/4885ALDH1A1 4848/4885 |
| US-12544416-B2 | Manufacturing method for composition promoting bone density enhancement | GYS1, GYS2, GSK3A | ACHE 45/4885NPC1 2928/4885ALDH1A1 4380/4885 |
| US-12582686-B2 | Manufacturing method for composition promoting recovery of bone fracture | CYC1, AGER, CYCS | ACHE 973/4885NPC1 4536/4885ALDH1A1 2503/4885 |
| US-20250388597-A1 | BIFUNCTIONAL PHOTOCROSSLINKING PROBES FOR COVALENT CAPTURE OF PROTEIN-NUCLEIC ACID COMPLEXES IN CELLS | PCNA, DDB1, DCLRE1A | ACHE 4713/4885NPC1 4232/4885ALDH1A1 3514/4885 |
| US-20220118064-A1 | MULTI-SUPPLEMENT COMPOSITIONS | SLC5A6, FABP2, GLS2 | ACHE 1408/4885NPC1 2051/4885ALDH1A1 2819/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.